
Form FDA 3674 - Certifications to Accompany …
Requiring a certification (Form FDA 3674) to accompany certain applications and submissions submitted to FDA is, therefore, one way of encouraging compliance with the provisions of the …
IND Forms and Instructions - FDA
2022年3月31日 · Form FDA 3674 (PDF - 3MB): Certification of Compliance; Form FDA 3454 (PDF - 47KB): Certification: Financial Interests and Arrangements of Clinical Investigators
汇总整理FDA药品注册中使用的表格 - 知乎 - 知乎专栏
· Form FDA 3674 (PDF - 3MB): Certification of Compliance,合规性认证表格是FDA要求申请人在提交新药或医疗器械申请时填写的一份表格。它用于确认申请人的产品在制造和分销过程中符合 …
certification form (Form FDA 3674) to be used to satisfy the certification requirement. The Form FDA 3674 can be obtained at:
Form 3674 must accompany an application/submission, including certain amendments, supplements, and resubmissions, submitted under §§ 505, 515, 520(m), or 510(k) of the …
[药品研发] FDA新药临床试验的法规管理 - 蒲公英
2018年11月12日 · 3674表格,需要登录美国NIH的Clinical Trials.gov网站,获得登记号,将此号填入3674表。 也就是说,所有FDA的临床试验都要求在Clinical Trial.gov登录。 首页函 (cover …
Initial IND Application | Clinical Center - National Institutes of ...
The Form FDA 3674 is a document that must accompany the initial submission, and when submitting a new protocol to IND. It is a signed statement from the sponsor that they will …
Clinical Trial Forms | FDA - U.S. Food and Drug Administration
This page provides links to commonly used clinical trial forms relevant to clinical trials. For other FDA forms, visit the FDA Forms page.
Regulatory Guidance for Academic Research of Drugs and Devices …
2025年3月11日 · The FDA form 3674 is a document that must accompany all FDA IND initial submissions and submission of new protocols to INDs. It is a signed statement from the …
美国IND注册流程简述 - 知乎 - 知乎专栏
IND申请主要基于2个目的:1.提供数据表明初始用于人体 FIH 的安全合理性;2.该药物是否具有药理活性,具备商业可开发性。 IND审评主要基于受试者安全性和权益,使研究性药物能跨州运 …